# Efficacy and Safety of Aripiprazole in First Episode Psychosis

> **NCT01026584** · PHASE4 · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 55 (actual)

## Conditions studied

- First Episode Psychosis

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT01026584
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2012-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026584, "Efficacy and Safety of Aripiprazole in First Episode Psychosis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01026584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*